关于药物和治疗学的医学信函 SCIE

期刊简介预计审稿时间： 较慢,6-12周

The Medical Letter, Inc. is committed to providing objective, practical, and timely information on drugs and treatments of common diseases to help our readers make the best decisions for their patients—without the influence of the pharmaceutical industry.

The Medical Letter On Drugs and Therapeutics is a biweekly publication that provides:

Evidence-based, peer-reviewed evaluations of new FDA-approved drugs with conclusions reached by a consensus of experts

New information on previously approved drugs including pivotal clinical trials, new indications, and safety warnings

Consensus recommendations for the preferred and alternative treatments for common disorders

Comparative reviews of drugs for a given indication with particular attention to clinical efficacy, adverse effects, drug interactions, and cost.

《医学快报》致力于提供客观、实用、及时的常见疾病药物和治疗信息，帮助我们的读者为患者做出最佳决策，不受制药行业的影响。

《医学快报：药物和治疗学》是一份双周刊，提供：

基于证据、同行评审的 FDA 批准新药评估，结论由专家达成共识

有关先前批准药物的新信息，包括关键临床试验、新适应症和安全警告

常见疾病首选和替代治疗的共识建议

针对特定适应症的药物进行比较性评价，特别关注临床疗效、不良反应、药物相互作用和成本。

《Medical Letter On Drugs And Therapeutics》(关于药物和治疗学的医学信函)编辑部通讯方式为MED LETTER INC, 1000 MAIN STREET, NEW ROCHELLE, USA, NY, 10801。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。